SPRR2A and hepatocellular carcinoma: Lp 12, Lp 355 inhibited HCC cell growth in the two highest concentrations 107 CFU/well and 108 CFU/well, even more than caused by sorafenib at human plasma concentration (13.8 μM) (Supplementary Figure S7A).